Decongestive diuresis using combination intravenous loop diuretics plus chlorothiazide in type 1 acute cardiorenal syndrome and worsening acute kidney injury; a neglected paradigm in resource-poor settings
Over the last decade or more, there has grown a body of evidence demonstrating that renal dysfunction in heart failure is a combination of forward failure from reduced cardiac output and therefore reduced glomerular filtration rate, as well as "congestive renal failure" secondary to renal...
Saved in:
Main Author: | Macaulay Amechi Chukwukadibia Onuigbo (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The guiding evidence based therapy using biomarker intensified treatment in heart failure (GUIDE-IT) study; the utility of decongestive diuresis in type 1 cardiorenal syndrome with rising pro-BNP levels
by: Macaulay Amechi Chukwukadibia Onuigbo
Published: (2018) -
Renal congestion related to worsening renal function in patients with acute decompensated heart failure: Diuretic strategy for acute cardiorenal syndrome
by: Michiya Ohno, et al.
Published: (2018) -
The use of modified Ponticelli regimens for primary membranous nephropathy
by: Macaulay Amechi Chukwukadibia Onuigbo
Published: (2019) -
Cytomegalovirus glomerulopathy in renal allografts
by: Macaulay Amechi Chukwukadibia Onuigbo
Published: (2020) -
Loop Diuretics in Acute Kidney Injury Prevention, Therapy, and Risk Stratification
by: Daniel Patschan, et al.
Published: (2019)